Member Info for PhatStyle4321

The share price is ridiculous and is being manipulated with the sell orders that keep appearing, any decent buying volume will be able to take these out, one way or another this share is going higher. This variant is coming and is here to stay , numbers are back up to 50,000!!!

Literally going in the same direction as the last pandemic, testing demand will rocket and NYCT has approved tests. Contracts will continue to flood in

Back pushing to 40p today, cases have jumped massively everyone needs to test and looks like a RNS is coming tomorrow

This is going one way tomorrow and that is up, massively oversold and worth a lot more

This is definitely oversold and news could drop anytime, revenues increasing nicely. 40p target by Friday easy, get in before you miss the boat IMO

Someone knows something, but already the company is undervalued, back to 100p

Something is coming

https://news.sky.com/story/covid-19-nervtag-scientists-cant-rule-out-omicron-causing-biggest-wave-of-infections-yet-that-may-overwhelm-nhs-12483709

Doesn’t look like this is going away, Delta is still around and now we have an extra variant to add to the mix. Absolutely crazy to see the share price this low

Typical MM games being played here, should see back to £4 if so some people will be regretting selling out at £3.50. Variant still a mystery and news is changing all the time. One thing is for sure more testing will be required for a while

New contracts should be landing any minute

Bodes well that PCR tests will be needed for arrivals until at least March, demand for PCR and specific to detecting Omicron will skyrocket.

This should wake people up today that NCYT will be a winner here

https://www.independent.co.uk/news/uk/politics/labour-covid-travel-tests-omicron-b1967021.html?amp

Can see revenues are going to increase dramatically over the. coming months, testing is going to be required in order for us to have a free way of living.

This new variant is looking like a lockdown and Novacyt products will once again be in demand. Expect this to double very quickly

Totally agree on your comments about SA he is one in a million, great update

That got me excited too Nick, I believe revenues could come as soon Q1. Now wouldn’t that see us much higher

No bad news, everything progressing nicely with revenue anticipated in 2022 !!, that will be a 2nd revenue stream.

Back to the 60’s if you ask me, completely oversold here

I think all eyes will be on how Croda is progressing, and any positive news here will once again ignite the share price. It will be interesting to see how far they have developed. Expected revenues will also be eagerly watched. If we can have 2 revenue streams turned on within succession, then I would say that is very very good going, however until an update is processed it is a guessing game.

I agree Clock, it is an opportunity to acquire more shares at a discount, a Croda update could drop at anytime and this will excite many investors including myself. This will centre stage while we have the probiotic sales in the background, what isn’t there to like at the moment, I feel a lot of sellers are going to be regretting not getting more at this price when we are back at 70

Looking at the previous RNS’s it seems final results were released December 4th 2020, not sure if they would do the same again this year.

I suspect the company is extremely busy with the sale of their probiotic and other projects in the pipeline. 55p seems to be the bottom and can see us pushing higher from here, back to 70p in no time